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Abstract
Ether lipids are ubiquitous constituents of cellular membranes with no discrete cell biological function assigned yet. Using
fluorescent polyene-ether lipids we analyzed their intracellular distribution in living cells by microscopy. Mitochondria and
the endoplasmic reticulum accumulated high amounts of ether-phosphatidylcholine and ether-phosphatidylethanolamine.
Both lipids were specifically labeled using the corresponding lyso-ether lipids, which we established as supreme precursors
for lipid tagging. Polyfosine, a fluorescent analogue of the anti-neoplastic ether lipid edelfosine, accumulated to
mitochondria and induced morphological changes and cellular apoptosis. These data indicate that edelfosine could exert its
pro-apoptotic power by targeting and damaging mitochondria and thereby inducing cellular apoptosis. In general, this
study implies an important role of mitochondria in ether lipid metabolism and intracellular ether lipid trafficking.
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Introduction
One fifth of all glycerophospholipids in humans are ether lipids
featuring an alkyl chain at the sn-1 position and commonly an
ethanolamine or choline head-group [1]. Highly abundant in certain
tissues ether lipids are linked to pathologies and genetic disorders
although their biological function remains unclear [2]. An involve-
ment in membrane organization, fusion and trafficking or intracel-
lular signaling and protection against oxidative stress is discussed
[1,3,4]. Changed levels link to neurological dysfunction and
degeneration [1,5]. Inactivation of ether lipid biosynthesis in mice
causes male infertility, defects in eye development, cataract and optic
nerve hypoplasia [2]. Little detail of the subcellular localization of
ether lipids is known; although synthesized in peroxisomes and the
endoplasmicreticulum(ER),theyalsooccurintheplasmamembrane
(PM), post-Golgi compartments and lipid droplets, LDs [1,2,6,7].
Neutral ether lipids contribute 20% to the LD core and ether-
phosphatidylcholine,ePC,and ether-phosphatidylethanolamine,ePE
were detected in the surrounding monolayer [7].
Several synthetic ether lipids, the prototype being edelfosine (1-
O-octadecyl-2-O-methyl-glycero-3-phosphocholine), show anti-
neoplastic activity [8–10]. The metabolically stable edelfosine
induces a selective apoptotic response in cancer cells, sparing
normal cells [11,12] unless these are in a proliferate state [13].
This selectivity arises from the internalization step [14–16] as the
drug is only readily incorporating into cellular membranes of
malignant cells [17,18]. Edelfosine-induced apoptosis involves
mitochondria [19,20] and caspase-3 activation [20], but the
underlying mechanism is complex as many cellular processes e.g.
PC biosynthesis [21–23], signaling [24] and intracellular transport
[25,26] are affected.
Polyene lipids are fluorescent lipid analogues of high structural
similarity to natural lipids [27]. Microscopy of polyene lipids holds
the invaluable advantage of studying lipids in living cells avoiding
compromises inherent to subcellular fractionation and purification
approaches. Here, we employ polyene-ether lipids to visualize
their subcellular distribution. Polyfosine, a fluorescent analogue of
edelfosine, is used to elucidate the cellular localization of the
bioactive compound and gain insights into its action.
Materials and Methods
Materials
Mitotracker Red CMXRos and Lysotracker Red DND-99 were
from Invitrogen (Carlsbad, CA, USA). LD540 has been described
[28]. Antibodies against Hsp60, Calnexin or cytochrome C were
from Stressgen (Farmingdale, NY, USA), against active caspase-3
or COX IV from Cell Signaling (Danvers, MA, USA), against
actin or tubulin from Sigma (Taufkirchen, GER), against Smac
from MBL (Woburn, MA, USA).
Edelfosine was from Sigma, other ether lipids (Fig. 1) were
synthesized as described in Text S1.
Methods
COS7 (from ATCCH, Number: CRL-1651) cell culture and
delivery, extraction, TLC and detection of lipids were performed
as described [27].
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Mass spectrometry (MS)
Cells were washed sequentially with PBS, 155 mM ammoniu-
macetate pH6.9 and HES (2 mM Hepes, 1 mM EDTA, 250 mM
sucrose, pH 7.0) and scraped. Lipids were extracted as described
[29]. Lipids were dissolved in chloroform/methanol/2-propanol
(1:2:4) containing 7.5 mM ammoniumacetate and analyzed by
multiple precursor ion scanning on a QSTAR-Pulsar-i quadrupole
time-of-flight mass spectrometer (AB SCIEX, Concord, ON,
CAN) equipped with a robotic nanoflow ion source Triversa
NanoMate (Advion Biosciences Inc., Ithaca, NJ USA) [30,31].
Plasmanyl-PC species were detected by precursor ion scanning
(PIS) m/z 456.3 analysis [32]. Plasmanyl-PE and plasmenyl-PE
species were detected by PIS m/z 428.2 and PIS m/z 426.2
analyses, respectively [33]. Detected lipid precursors were
identified using Lipid View software (AB SCIEX) [31]. Alterna-
tively, endogenous PC, ePC, PE and ePC species were profiled by
high-resolution positive ion mode fourier transform MS analysis
on a LTQ Orbitrap XL mass spectrometer (Thermo Fisher
Scientific) equipped with a Triversa NanoMate.
Cell fractionation
Cells were washed and collected as above, followed by
homogenization in a cooled EMBL cell cracker (HGM, Heidel-
berg, GER) with 8 strokes using a maximum clearance of 18 mm.
To purify the mitochondria by differential centrifugation the
supernatant (PNS, post nuclear supernatant) after a first
centrifugation step (100–1,0006g; 2–5 min, respectively) was
separated from the pellet (PNP, post nuclear pellet) and
centrifuged again (10,0006g; 10 min) to obtain a crude mito-
chondria pellet (PMP, post mitochondrial pellet) and a supernatant
(PMS, post mitochondrial supernatant). The PMP was redissolved
in HES and layered on top of a step gradient (40%, 26% and 12%
Percoll in HES). The gradient was centrifuged (25 min,
150,0006g) before harvesting 8 fractions from the top. Samples
were subjected to SDS-PAGE and Western blotting.
Microscopy
Two-photon-excited fluorescence microscopy of living cells was
performed as described [27]. Epifluorescence microscopy of living
and fixed cells was performed using a Zeiss Observer.Z1
microscope (Carl Zeiss, Oberkochen, GER) equipped with a C-
Apochromat 636 (1.20 NA) and a Photometrics Evolve camera,
or a Plan-Apochromat 636 (1.40 NA) DIC and a Photometrics
Coolsnap K4 camera, respectively. Live cells imaging was
performed at 37 degree C in a 5% carbondioxid atmosphere.
Light source was a Polychrome V 150 W xenon lamp (TillPho-
tonics, Gra ¨felfing, GER). Confocal immuno-fluorescence laser
scanning microscopy of fixed cells was performed using a Leica
TCS SP2 microscope (Leica, Wetzlar, GER) equipped with a
HCX PL APO CS 406 (1.25 NA). Relief contrast bright field
microscopy of living cells was performed using an Olympus
CKX31 microscope (Olympus, Hamburg, GER) equipped with a
LCACHN 20xRC (0.4 NA) and a halogen light source. Images
were acquired with Canon Powershot digital camera (Canon,
Amsterdam, NED). Phase-contrast video microscopy of living cells
was performed using an Olympus IX70 microscope (Olympus)
equipped with a U-Plan S Apo 1006 (1.40 NA) and a primary
halogen lamp light source. A secondary light source, a Polychrome
II 75 W xenon lamp (TillPhotonics) with its soft shutter
wavelength set to 280 nm, and an FT395-LP415 (Carl Zeiss)
was used to illuminate the cells continuously with broadband UV
light. Digital images were acquired with a NTE/CCD-512-EBFT
camera (Roper Scientific, Ottobrunn, GER). All images were
processed employing Adobe Photoshop 6.0 (Adobe).
Results
Polyene-ether lipids derived from alkyl glycerol
precursors
We fed polyene-alkyl glycerols to cells and analyzed the
fluorescent metabolic products by TLC. From 50 mM concentra-
tions of c16:5-alkyl-glycerol or c20:5-alkyl-glycerol, the cells
produced primarily neutral ether lipids (ether-diglycerides, eDG;
ether-triglycerides, eTG) and ether glycerophospholipids (ePE,
Figure 1. Ether lipids used in this study. Simplified names are black boxed. All lyso-lipids are sn-2-lyso-lipids.
doi:10.1371/journal.pone.0031342.g001
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(Fig. 2A and B). Differences in alkyl chain lengths did not influence
the labeling pattern, also when 3 mM concentrations were used
(data not shown). Considerable amounts of precursor, whose
concentration decreased only slowly during a chase, were
detectable. Studying the distribution of polyene-ether lipids in
living cells by two-photon-microscopy (Fig. 2C) revealed a staining
of the nuclear envelope, ER, LDs and mitochondria. To
unequivocally identify the latter we performed epifluorescence
microscopy colocalization studies (Fig. 2D). LDs and mitochondria
were confirmed to contain polyene-ether lipids. Peroxisomes did
not accumulate ether lipids as shown before [27].
Polyene-ether lipids derived from lyso-ether lipid
precursors
A shortcoming of using alkyl glycerols for ether lipid tagging is
the limited specificity. Labeling selectivity was greatly increased
when cells were incubated with polyene lyso-ether lipids.
Application of polyene-lyso-ePE yielded fluorescent ePE upon
cellular acylation (Fig. 3A). At later timepoints (60–120 min)
minimal labeling of ePC could be detected as also natural ePC is
synthesized from ePE [1]. During a 2 h chase the precursor
concentration was reduced by 70%. When cells were incubated
with polyene-lyso-ePC, cellular acylation yielded ePC with high
specificity and rate (Fig. 3B). During the 2 h chase the precursor
was converted to only ePC. Uptake and specificity of various
polyene precursors were quantified (Fig. 4). The alkyl glycerol was
taken up 5-fold more efficiently (Fig. 4A), but after 60 min
incubation the lyso-ether lipids showed a 8-fold or 5-fold higher
labeling specificity for the desired lipid class (Fig. 4B and C), which
increased further during a chase.
To identify the fatty acids used for cellular acylation of polyene
lyso-ether lipids MS analyses were performed (Table 1). Arachi-
donic acid (20:4) was the predominant acylation partner for both
polyene-lyso-ePE and -ePC. Other endogenous unsaturated fatty
acids, oleate (18:1), linoleate (18:2), and palmitoleate (16:1) were
also detected. These findings are expected, since ePE and ePC
species are rich in polyunsaturated fatty acids in untreated COS7
cells (Fig. S1) and other cells [1]. The 6-fold higher abundance of
palmitate (16:0) and the presence of myristate (14:0) in ePC, but
not in ePE (Table 1) might point to a different specificity of the
acyltransferases with a higher acceptance of saturated acyl chains
in ePC compared to ePE. The concentration of vinylated polyene
plasmenyl-PE was 24-fold lower than that of polyene plasmanyl-
PE. Due to peak overlay plasmenyl-PC could not be analyzed. MS
analysis did not indicate any significant conversion of polyene ePE
or ePC into ether-phosphatidylserine, ePS, or ePA. Taken
together, polyene-lyso-ether lipids are acylated by cellular enzymes
without apparent disturbances by the tag.
Ether lipids in mitochondria and ER
The specific labeling of ePE or ePC obtained using the
respective polyene-lyso-ether lipid allowed for the localization of
fluorescent ePE and ePC on the subcellular level in living cells for
the first time. Two-photon-excitation microscopy revealed that
ePE and ePC prominently stained the mitochondria, nuclear
envelope and ER (Fig. 5). LD staining was not detected, as only
minor amounts of fluorescent neutral ether lipids were biosynthe-
sized during the experiment (Fig. 3).
When cells were incubated with polyfosine, a fluorescent
analogue of the metabolically stable, synthetic ether lipid
edelfosine, no significant metabolites could be detected within
Figure 3. Metabolism of polyene-lyso-etherlipids in COS7 cells. Cells were incubated with 50 mM of c16:5-lyso-ePE (A) or c16:5-lyso-ePC (B)
for different pulse times. Fresh medium was applied for chase times. Lipid were extracted and analyzed by TLC for fluorescent metabolites, which
were identified by comigrating lipid standards.
doi:10.1371/journal.pone.0031342.g003
Figure 2. Metabolism and intracellular distribution of polyene-alkyl-glycerols in COS7 cells. Cells were incubated with 50 mM of c16:5-
alkyl-glycerol (A, C, D) or c20:5-alkyl-glycerol (B) for different pulse times (A & B), 2 h (C) or 0.5 h (D). Cellular lipids were extracted and analyzed by TLC
for fluorescent metabolites, which were identified by comigrating lipid standards (A & B). Living cells were imaged using two-photon-excitation
microscopy (C) or epifluorescence microscopy (D). Merged color images show ether lipids in green and LDs, mitochondria, or lysosomes stained by
LD540, Mitotracker, or Lysotracker, respectively, in red (D). Bars, 20 mm. ori, origin of application.
doi:10.1371/journal.pone.0031342.g002
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respectively.
label m/z lipid species rel. int. [%] m/z lipid species rel. int. [%]
lyso- 638.4 ePE(O-16:5/14:0) 2 636.4 ePE(P-16:5/14:0) 2
ether- 664.4 ePE(O-16:5/16:1) 23 662.4 ePE(P-16:5/16:1) 17
PE 666.5 ePE(O-16:5/16:0) 8 664.4 ePE(P-16:5/16:0) 10
690.5 ePE(O-16:5/18:2) 21 688.4 ePE(P-16:5/18:2) 25
692.5 ePE(O-16:5/18:1) 45 690.5 ePE(P-16:5/18:1) 45
694.5 ePE(O-16:5/18:0) 2 692.5 ePE(P-16:5/18:0) 8
714.5 ePE(O-16:5/20:4) 100 712.4 ePE(P-16:5/20:4) 100
716.5 ePE(O-16:5/20:3) 8 714.5 ePE(P-16:5/20:3) 13
lyso- 740.5 ePC(O-16:5/14:0) 22
ether- 766.5 ePC(O-16:5/16:1) 36
PC 768.5 ePC(O-16:5/16:0) 55
792.5 ePC(O-16:5/18:2) 40
794.5 ePC(O-16:5/18:1) 21
796.5 ePC(O-16:5/18:0) 3
814.5 ePC(O-16:5/20:5) 14
816.5 ePC(O-16:5/20:4) 100
818.5 ePC(O-16:5/20:3) 15
‘‘O’’ indicates plasmanyl, ‘‘P’’ plasmenyl lipids.
doi:10.1371/journal.pone.0031342.t001
Figure 4. Uptake and labeling specificity of various polyene-ether lipid precursors. The total amount of fluorescent lipids in COS7 was
determined by fluorescence spectroscopy and plotted over incubation time (A). Fluorescent ePC (B) or ePE (C), derived from c16:5-alkyl-1-glycerol (B
& C, closed circles) or c16:5-lyso-ePC (B, open circles) or c16:5-lyso-ePE (C, open circles), respectively, was quantified from TLC plates (Figs. 2 & 3).
Results from a single experiment are displayed as background-corrected percent values of total fluorescence in the TLC lane.
doi:10.1371/journal.pone.0031342.g004
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pronounced polyfosine staining of mitochondria with a noticeable
marking of nuclear envelope, ER and PM (Fig. 7). Long
incubation with polyfosine resulted in shortened or swollen
mitochondria (Fig. 7B and C). Colocalization studies confirmed
the accumulation to mitochondria (Fig. 7D), while lysosomes
contained hardly any detectable polyfosine (Fig. 7E).
The impact of polyfosine and edelfosine on mitochondria
To compare the potentials of edelfosine and polyfosine to
induce cellular apoptosis the activation of caspase-3 in immortal
COS7 cells was monitored by microscopy and Western Blotting
(Fig. 8). The number of caspase-3 positive cells and its
concentration increased over time, faster for edelfosine compared
to polyfosine treatment. Long incubation times resulted in
decreased cell viability and number, due to apoptosis-induced
detachment (Fig. 8A and Fig. S2).
To compare the inhibition of PC biosynthesis by edelfosine and
polyfosine the incorporation of a radio-labeled fatty acid into PC
was assayed (Fig. 9A). After an initial decrease in the incorporation
rate, edelfosine treated cells stopped the synthesis and remodeling
of PC. Longer polyfosine treatment also reduced the amount of
labeled PC, although less efficiently. To corroborate these findings
we analyzed the major cellular lipid classes by MS (Fig. 9B). The
PC and PE contents were quantified relative to the sum of major
lipids. After 1 h treatment, edelfosine decreased the total PC
content by about 38%, polyfosine by 18% compared to control
cells (Fig. 9B).
Figure 5. Imaging of polyene-ether phospholipids in COS7 cells. Cells were incubated with 50 mM lyso-ePE (A & B) or lyso-ePC (C & D) for 1 h
(A & C) or 1 h+2 h chase (B & D). Fresh medium was applied for chase times. Cellular metabolism generated mostly ePE (A & B) or ePC (C & D) (see
Fig. 3 A & B, respectively). Living cells were imaged using two-photon-excitation microscopy. Note, that the reticular ER staining appears less defined
after the chase (B & D). Bars, 20 mm.
doi:10.1371/journal.pone.0031342.g005
Figure 6. Metabolism of polyfosine in COS7 cells. Cells were
incubated with 50 mM of polyfosine for different times. Lipids were
extracted and analyzed by TLC for fluorescent metabolites, which were
identified by comigrating lipid standards.
doi:10.1371/journal.pone.0031342.g006
Imaging of Ether Lipids
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31342The morphological changes of mitochondria upon polyfosine
accumulation were studied by fluorescence microscopy employing
a dye sensitive to mitochondrial activity and vitality (Fig. S3A). In
control cells mitochondria were often elongated and stained with
similar intensities. Many polyfosine and all edelfosine treated cells
had short and fragmented mitochondria (Fig. S3B). While many
apoptotic cells upon polyfosine treatment did not accumulate the
dye, edelfosine treated cells with condensing nuclei or arrested in
mitosis often showed intensively stained mitochondria with an
increased cellular background stain (Fig. S3A). Mitochondrial
fragmentation leads to changes in organelle size, shape and
density, which prevented their isolation by density gradient
centrifugation to a satisfying purity from contaminating ER (Fig.
S4).
Mitochondrial fragmentation was analyzed by phase-contrast
video microscopy (Fig. 10 and Movie S1). After 10 min some
polyfosine and edelfosine treated cells started mitochondrial
fragmentation, while others followed after 15–25 min. Shortly after
fragmentation the mitochondria of polyfosine, but not edelfosine
treated cells condensed and disintegrated, followed by nuclear
condensation. Control cells incubated with carrier or polyene-lyso-
ePC, the latter sharing the fluorophore and the cellular localization
with polyfosine (Fig. 5C and D) showed no morphological changes.
Blebbed mitochondria upon polyfosine treatment were also
Figure 7. Imaging of polyfosine in COS7 cells. Cells incubated with 50 mM of polyfosine for 1 h (A, D & E), 2.5 h (B), or 5 h (C) were imaged by
two-photon-excited lipid fluorescence (A–C) or epifluorescence (D & E) microscopy. Merged color images show polyfosine in green (D & E) and
mitochondria (D) or lysosomes (E) stained by Mitotracker or Lysotracker, respectively, in red. Polyfosine stained convoluted PM ruffles (D, arrow
heads). Bars, 20 mm.
doi:10.1371/journal.pone.0031342.g007
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disintegration was significantly accelerated during video microscopy
likely caused by the continuous UV illumination of the imaged cells.
Apparently, the phototoxicity potentiated the membrane-disrupting
effects of fluorescent polyfosine, but not edelfosine, known for its
radiosensitizing properties [34].
Figure 8. Induction of apoptosis in COS7 cells by polyfosine or edelfosine. (A) Cells incubated with 10 mM of polyfosine or edelfosine for
indicated times were fixed and probed for activated caspase-3, a landmark of apoptosis. After 18 h many apoptotic cells had detached from support.
Confocal laser immuno-fluorescent microscopy images are shown as inverted grayscale. Bars, 50 mm. (B & C) Lysates of cells incubated with 10 mMo f
polyfosine or edelfosine for indicated times were assayed by Western blotting for activated caspase-3 and for a-tubulin, which served as a load
control. (C) Signal intensities from four Western blots were quantified. Shown is the amount of activated caspase-3 corrected for background and
normalized to the a-tubulin signal. The amount of active caspase-3 in edelfosine treated cells was set to 100.
doi:10.1371/journal.pone.0031342.g008
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Information on the subcellular localization of most ether lipids is
limited. Using polyene lyso-ether lipids, which upon cellular
acylation yielded fluorescent ePC or ePE, allowed for their
unprecedented individual microscopic analysis. Both ether phos-
pholipids strongly accumulated to mitochondria, besides the ER.
The fact that fluorescent ePC or ePE was not detectable on LD
monolayers [7] or the PM [4] likely reflects limitations in optical
resolution and detection sensitivity. Polyene-sphingolipids were
not accumulating on mitochondria arguing against an erratic
targeting of the fluorophore to mitochondria [27]. Comparing the
labeling patterns of polyene lyso-ether lipids and alkylglycerols we
established lyso-ether lipids as supreme precursors for phos-
phoether lipid tagging as they represent a good compromise
between labeling specificity, similarity to natural lipids and
applicability to cells. Cell derived polyene-ePC and -ePE, like
natural ether glycerophospholipids [1], often contained unsatu-
rated fatty acids most prominently arachidonic acid. Placed to
mitochondria ether lipids might serve as a sink for harmful
oxidants resulting from oxidative phosphorylation. However, only
a small amount of polyene-ePE was detected as vinylated
plasmenyl-ePE with antioxidative properties [2]. Alternatively,
mitochondria undergo extensive fusion and fission cycles [35] as
do synaptic vesicles, which show high plasmalogen concentrations
[36]; ether phospholipids might facilitate membrane reorganiza-
tion in both cases.
After lyso-ether lipid feeding mitochondria became the first
labeled organelles justifying speculations of the underlying
targeting mechanism. The structure of lyso-ether lipids supports
a non-facilitated transport between membranes. For instance, the
related lyso-PC is spontaneously released from membranes within
milliseconds, which allows for rapid kinetic equilibration [37]. Its
release and cytosolic transport are supported by fatty acid binding
proteins [38]. Mitochondria may provide the enzyme for lyso-
ether lipid acylation, which would arrest the resulting ether lipid in
the mitochondrial membrane. Tafazzin, a phospholipid acyltrans-
ferase catalyzing transacylation between lyso-PC and cardiolipin
[39] represents a candidate.
Alternatively, ePC and ePE generated by non-mitochondrial
acyltransferase(s) could be targeted to mitochondria by a
mechanism also accessible to the synthetic ether lipids polyfosine
and edelfosine. Especially for the latter, a raft-dependent
endocytosis step has been discussed and is supported by the
enrichment of both edelfosine [16,40] and ether lipids [4] in rafts.
Alternatively, membrane continuities between organelles could be
involved as reported for lipid trafficking before [41]. Noteworthy,
many other cellular organelles including LDs, which act as a
cellular sink for hydrophobic xenobiotics [42] did not accumulate
polyfosine, arguing for a specific rather than a stochastic
enrichment at mitochondria.
One may not expect polyfosine enrichment in mitochondria as
edelfosines established molecular targets are located to the ER and
PM [16]. Labeling by a fluorescent phenylpolyene-analogue of
edelfosine was restricted to the PM in leukemic cells or predomi-
nantly found in the ER of solid carcinoma yielding a model where
the cell specific distribution pattern correlates with different cellular
targets [43,44]. A recent study performed in HeLa cells uses
fluorescent borondifluorodipyrromethene (BODIPY) coupled edel-
fosine analogues and confocal laser microscopy to describe a
mitochondrial localization of these probes [45]. Polyfosine, the
analoguematching bestthechemicalstructure of edelfosine confirms
mitochondria as a target for the drug in COS7 cells, while verifying
anERandPMlocalization.Celltypeordifferentcellularhandlingof
the various analogues may explain the discrepancy in localization of
the fluorescent analogues.Mitochondriallocalizationmaybehardto
detect if only non-confocal microscopic images are available [43,44]
as ER staining can interfere.
While polyfosine and edelfosine activated caspase-3 and
interfered with PC biosynthesis our study supports the notion
that the accumulation of these lipids to mitochondria per se results
in a structural damage of the organelle that ultimately leads to
apoptosis. These inverted cone-shaped lipids possibly generate
membrane curvature if high local concentrations are met [46].
Indeed, edelfosine induced swelling of isolated mitochondria [45]
and membrane destabilization in liposome model systems by
formation of interdigitated structures, micelles and small vesicles
[47]. Edelfosine’s detergent properties [10] and very low critical
micellar concentration were found to cause lipid solubilization
and, importantly, release of content from lipid vesicles [48].
Physical membrane destabilization and loss of mitochondrial
integrity results in release of mitochondrial proteins like cyto-
chrome c [49], which ultimately induces apoptosis [35].
In summary, this study establishes polyene lyso-ether lipids as
supreme precursors for phosphoether lipid tagging. Fluorescent
Figure 9. Inhibition of PC synthesis. (A) COS7 cells were incubated with 10 mM polyfosine (closed circles) or edelfosine (open circles) in the
presence of [3H]-myristic acid. At indicated times lipids were extracted and analyzed by TLC for radioactive metabolites. The signal intensity of
labeled PC was quantified from TLC plates. Data are mean values 6 range, n=2. Error bars smaller than symbol size are omitted. (B) COS7 cells were
incubated with 50 mM polyfosine or edelfosine for 1 h. Cellular lipids were extracted and analyzed by MS. The total PC and PE intensity was
normalized to the sum of all major lipids (PC, PE, SM, DG, TG, ePC and ePE). Data are mean values, n=2, with a range of less then three percent.
doi:10.1371/journal.pone.0031342.g009
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important role for the organelle in lipid trafficking.
Supporting Information
Figure S1 Analysis of glycerophosphatidylcholine and
glycerophosphatidylethanolamine lipids species of
COS7 cells by MS. Cells were grown in DMEM containing
4.5 g/ml glucose, GlutaMax I, pyruvate and 10% FCS. Total lipid
extracts of cells were analyzed for the PC and ePC (A), or PE and
ePE (B) species by high-resolution FT MS analysis. The intensity
of each species was quantified as a fraction of the sum of all
glycerophosphatidylcholine (A) or glycerophosphatidylethanola-
mine (B) species monitored. Lipid species with a relative amount of
less than one percent are omitted.
(TIF)
Figure S2 Analysis of the viability of COS7 cells upon
treatment with polyfosine or edelfosine. Cells were
incubated with 10 mM of polyfosine, edelfosine or carrier as
control for indicated times. Representative relief contrast micros-
copy images of the morphological appearance of the cells are
shown (A). Note, that after 3–6 h of incubation with either
polyfosine or edelfosine cells were rounding up and detaching
from the support presumably by apoptosis-induced detachment.
The nuclei appeared granular and fragmented. The number of
Figure 10. UV light induced phototoxicity. COS7 cells were incubated with carrier (A) or 50 mM of lyso-ether PC (B), edelfosine (C) or polyfosine
(D). Living cells were imaged by phase-contrast video microscopy for at least 60 min, during which a broadband UV illumination from a second light
source was constantly applied. Bars, 20 mm. Mitochondria fragmented (C & D) and disintegrated (D). See also Movie S1.
doi:10.1371/journal.pone.0031342.g010
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rounded up cells with granular fragmented nuclei) were counted
and used to calculate the percentage of viable cells (B).
(TIF)
Figure S3 Morphological changes of mitochondria and
nuclei upon polyfosine or edelfosine treatment of COS7
cells. Cells were incubated with 50 mM polyfosine, edelfosine or
carrier for the indicated times. Mitotracker, whose accumulation
depends on mitochondrial activity and vitality, was added prior
fixation and fluorescence microscopy (A). Merged color images
show green nuclei and red mitochondria, stained by DAPI or
Mitotracker, respectively. Bars, 50 mm. (B) Cells with fragmented
mitochondria were counted from microscopy images (70–200 cells
total for each time point).
(TIF)
Figure S4 Isolation of mitochondria from COS7 cells
incubated with polyfosine or edelfosine. Cells incubated
with carrier (control) or 50 mM polyfosine or edelfosine for 1 h
were harvested and homogenized. A crude mitochondria pellet
was prepared as described under Material and Methods and
separated from a cytosol-enriched supernatant (PMS, post
mitochondrial supernatant). The crude mitochondria fraction
(crude) was loaded onto a Percoll gradient and centrifuged again
(150,0006g; 25 min) before 9 fractions were collected from the
top. Aliquots were analyzed by SDS-PAGE and Western blotting
for the mitochondrial proteins cytochrome c and cytochrome c
oxidase subunit IV (COX IV) and calnexin, an ER marker
protein. Note, that in contrast to control cells the mitochondria of
polyfosine or edelfosine treated cells cannot be separated from the
ER by density gradient centrifugation.
(TIF)
Figure S5 Disintegrated, blebby mitochondria and
condensed nuclei of COS7 cells upon polyfosine treat-
ment. Cells were incubated with 50 mM polyfosine for 5 h. For
the last 15 min before fixation the incubation medium was
supplemented with 20 nM Mitotracker dye whose accumulation
to mitochondria depends on their activity and vitality. The vitality
and morphology of mitochondria was analyzed by fluorescence
microscopy. Merged color images show nuclei in green, mito-
chondria in red, stained by DAPI or Mitotracker, respectively.
Bar, 50 mm.
(TIF)
Movie S1 UV light induced changes of cell morphology
upon polyfosine treatment. COS7 cells were incubated with
carrier (upper left) or 50 mM of lyso-ether PC (upper right),
edelfosine (lower left) or polyfosine (lower right). Living cells were
followed by phase contrast video microscopy for 33 min. During
the course of the experiment the cells were constantly illuminated
by broadband UV light from a second light source, a Xenon lamp.
Bar, 20 mm. Note the fragmentation of mitochondria (lower left
and right) and the disintegration of mitochondria and nuclei (lower
right).
(MOV)
Text S1.
(DOC)
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